共 213 条
[1]
Chen Z(2023)The pathogenesis and development of targeted drugs in acute T lymphoblastic leukaemia Br J Pharmacol 180 1017-1037
[2]
Xin Q(2019)Passweg JR [Acute lymphoblastic leukemia - diagnosis and therapy] Ther Umsch Rev Ther 76 510-515
[3]
Wei W(2020)Acute lymphoblastic leukaemia Lancet Lond Engl 395 1146-1162
[4]
Wu Y(2017)Changes of peripheral blood marrow-derived suppressor cell level after chemotherapy induction remission by VDLP regimen and their relationship with immune system in B-ALL children Zhongguo Shi Yan Xue Ye Xue Za Zhi 25 1611-4
[5]
Medinger M(2016)Application of Glutamine-enriched nutrition therapy in childhood acute lymphoblastic leukemia Nutr J 15 65-1186
[6]
Heim D(2021)Toward the cure of acute lymphoblastic leukemia in children in China JCO Glob Oncol 7 1176-41
[7]
Lengerke C(2018)CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies J Hematol Oncol 11 41-54
[8]
Halter JP(2019)CAR-T cells beyond CD19, UnCAR-Ted territory Am J Hematol 94 S34-571
[9]
Malard F(2021)CAR T-cells in acute lymphoblastic leukemia: current results Bull Cancer (Paris) 108 S40-199
[10]
Mohty M(2018)Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia Nat Med 24 563-374